Memory Disorders Program News Today

Kill his wife for money. Reporter that tipster set up a meeting between manejwala and an undercover cop. Police say they met three times and talked about how it would get done, how it would be made to look like a botchedni burgla or robbery. As soon as he began to offer money and information, that made it very evident that he was serious about this homicide. We began pursuing it that way. So now there will be additional investigation, but we dont know the motive at this point. Reporter police sa...

Him and the other kids on the bus who try to come to suarez aid. The students were able to flag down a deputy at the next bus stop, show him the video and that resulted in scarbroughts arrest. He was booked in the polk county jail on two charges child endangerment and assault causing bodily injury. He did post bond sunday and is now free. But has a no contact order with the victim and his family. Amanda and we expect to hear what the family thinks about this whole situation as this News Conferen...

New research shows women who follow the Dietary Approaches to Stop Hypertension or "DASH" diet may be able to preserve their cognitive health later in life. Here's what you need to know about the new study, the DASH diet, and how it impacts overall health.

Eisai Co.’s breakthrough Alzheimer’s drug — the first to show it slows the brain-destroying disease — is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties and

The same day Eisai’s Leqembi received full U.S. approval, Medicare officials said the government health program for the elderly will pay for it. But that doesn’t mean patients will be able to get the $26,500-a-year treatment quickly. Doctors at top medical centers said they’re still trying to coordinate required testing, reimbursement and a real-world monitoring system of patients’ side effects and cognitive status.

The FDA is expected to grant full approval to Leqembi, an Alzheimer’s drug from Eisai and Biogen.

The top Medicare official tasked with heading CMS’ drug price negotiation group signaled the agency might loosen its proposed requirement to restrict drug companies from disclosing details about the negotiation process.

A Milken professor will continue a 30-year study researching the relationship between Alzheimer's disease with prediabetes and Type 2 diabetes.

Can changes in the way a person manages their personal finances lead to an early diagnosis of Alzheimer’s disease? Georgetown researchers are developing machine learning algorithms to find out.

Leqembi’s manufacturers estimate the drug will be available by Jan. 23 and have priced the biweekly infusion at $26,500 annually.